Andrew Carrier
Overview
Explore the profile of Andrew Carrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Youden B, Yang D, Carrier A, Oakes K, Servos M, Jiang R, et al.
Environ Sci Technol
. 2024 Sep;
PMID: 39250346
The presence of metalloids and heavy metals in the environment is of critical concern due to their toxicological impacts. However, not all metallic species have the same risk level. Specifically,...
2.
Singh P, Chen Y, Youden B, Oakley D, Carrier A, Oakes K, et al.
Int J Pharm
. 2024 Jan;
652:123814.
PMID: 38280502
Dissolvable polymeric microneedles (DPMNs) have emerged as a powerful technology for the localized treatment of diseases, such as melanoma. Herein, we fabricated a DPMN patch containing a potent enzyme-nanozyme composite...
3.
Dong L, Chen Y, Gu L, Gan M, Carrier A, Oakes K, et al.
Biomed Pharmacother
. 2023 May;
164:114878.
PMID: 37209626
As an effective antioxidant enzyme, superoxide dismutase (SOD) has been widely used as a food supplement, cosmetic additive, and therapeutic agent. However, oral delivery of SOD is challenging due to...
4.
Singh P, Youden B, Carrier A, Oakes K, Servos M, Jiang R, et al.
J Control Release
. 2022 Dec;
353:1050-1067.
PMID: 36549390
Microneedles (MN) technology is an emerging technology for the transdermal delivery of therapeutics. When combined with photoresponsive (PR) materials, MNs can deliver therapeutics precisely and effectively with enhanced efficacy or...
5.
Singh P, Youden B, Yang Y, Chen Y, Carrier A, Cui S, et al.
ACS Appl Mater Interfaces
. 2021 Aug;
13(35):41464-41472.
PMID: 34448397
Multimodal nanotherapeutic cancer treatments are widely studied but are often limited by their costly and complex syntheses that are not easily scaled up. Herein, a simple formulation of glucose-oxidase-coated CuS...
6.
Wang L, Peng R, Liu X, Heng C, Miao Y, Wang W, et al.
Chem Commun (Camb)
. 2021 May;
57(45):5514-5517.
PMID: 33955439
Unwanted biofilms present challenges for many industries. Herein an innovative biofilm removal technology was developed based on nitrite-accelerated Fenton chemistry, where both dissolved Cu ions and nano-CuO surfaces efficiently generate...
7.
Singh P, Chen Y, Tyagi D, Wu L, Ren X, Feng J, et al.
Int J Pharm
. 2021 Apr;
602:120602.
PMID: 33862128
β-Cyclodextrin (β-CD) was grafted onto hyaluronic acid (HA) in a single step to generate a supramolecular biopolymer (HA-β-CD) that was explored for targeted drug delivery applications. Along with its excellent...
8.
Singh P, Wu L, Ren X, Zhang W, Tang Y, Chen Y, et al.
Int J Pharm
. 2020 Jun;
586:119542.
PMID: 32553494
Hyaluronic acid (HA), a common biopolymer found in the extracellular fluid, was grafted with β-cyclodextrin (β-CD) to form a composite polymer that could form inclusion complexes with tocopherol (VE), enhancing...
9.
Singh P, Zeng X, Chen X, Yang Y, Chen Y, Cui S, et al.
J Pharm Biomed Anal
. 2020 Mar;
185:113230.
PMID: 32169789
A rapid and sensitive liquid chromatography-tandem mass spectrometric method was developed and validated for the determination of HA15, an emerging anticancer compound targeting GSPA5/BIP delivered by dissolvable polymeric microneedles. The...
10.
Chen Y, Yang Y, Xian Y, Singh P, Feng J, Cui S, et al.
ACS Appl Mater Interfaces
. 2019 Dec;
12(1):352-360.
PMID: 31825580
Dissolvable polymeric microneedles (DPMNs) are promising transdermal drug delivery systems with minimal invasiveness and improved patient compliance. Incorporation of a small amount of graphene oxide (GO) in the biocompatible polymers...